N
MBIO icon

Nuveen’s Mustang Bio MBIO Stock Holding History

Nuveen’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,935
Closed -$1.32M – 3392
2022
Q1 		$1.32M Sell
1,935
-244
-11% -$200K ﹤0.01% 2693
2021
Q4 		$2.77M Sell
2,179
-58
-3% -$93.6K ﹤0.01% 2400
2021
Q3 		$4.83M Sell
2,237
-162
-7% -$348K ﹤0.01% 2231
2021
Q2 		$5.97M Sell
2,399
-447
-16% -$1.1M ﹤0.01% 2153
2021
Q1 		$7.09M Buy
2,846
+1,701
+149% +$5.06M ﹤0.01% 1987
2020
Q4 		$3.25M Buy
1,145
+951
+490% +$2.27M ﹤0.01% 2271
2020
Q3 		$459K Buy
194
+97
+100% +$239K ﹤0.01% 2977
2020
Q2 		$233K Sell
97
-13
-12% -$30.4K ﹤0.01% 3075
2020
Q1 		$221K Sell
110
-1
-0.9% -$2.56K ﹤0.01% 2979
2019
Q4 		$340K Sell
111
-111
-50% -$254K ﹤0.01% 2982
2019
Q3 		$542K Buy
222
+58
+35% +$159K ﹤0.01% 2921
2019
Q2 		$454K Buy
+164
New +$468K ﹤0.01% 3035

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Nuveen's MBIO Position: Q2 2022 in Review

Nuveen sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 1,935 shares — an estimated $1.32M sold.

Nuveen first reported a position in MBIO in Q2 2019 and held it in 12 quarters. The position peaked at $7.09M in Q1 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Nuveen reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,935 Mustang Bio shares in Q2 2022, an estimated $1.32M.
  • Nuveen first reported a position in Mustang Bio in Q2 2019 and held it in 12 quarters.
  • Nuveen's Mustang Bio position peaked at $7.09M in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.